Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma. | Oncogene | 2022 | 35422476 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas. | Clin Cancer Res | 2022 | 35421230 | PubTator, text mining | PubMed |
| Aptamer Nanomaterials for Ovarian Cancer Target Theranostics. | Front Bioeng Biotechnol | 2022 | 35419352 | PubTator, text mining | PubMed |
| Defending and integrating an organism by the immune system. | Scand J Immunol | 2022 | 35416326 | PubTator, text mining | PubMed |
| Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. | Nat Genet | 2022 | 35410377 | PubTator, text mining | PubMed |
| Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration. | Int J Mol Sci | 2022 | 35409356 | PubTator, text mining | PubMed |
| Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer. | Int J Mol Sci | 2022 | 35409038 | PubTator, text mining | PubMed |
| FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. | Cancers (Basel) | 2022 | 35406487 | PubTator, text mining | PubMed |
| A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. | Cancer Res | 2022 | 35405009 | PubTator, text mining | PubMed |
| Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia. | Front Immunol | 2022 | 35401501 | PubTator, text mining | PubMed |
| Experimental study of the catalytic effect of iron on low-rank coal gasification. | Sci Rep | 2022 | 35388136 | PubTator, text mining | PubMed |
| Primary intestinal Burkitt's lymphoma in a Syrian child with a challenging initial presentation: A case report and literature review. | Ann Med Surg (Lond) | 2022 | 35386777 | PubTator, text mining | PubMed |
| Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease. | Neuron | 2022 | 35381189 | PubTator, text mining | PubMed |
| A screen of repurposed drugs identifies AMHR2/MISR2 agonists as potential contraceptives. | Proc Natl Acad Sci U S A | 2022 | 35380904 | PubTator, text mining | PubMed |
| Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma. | Haematologica | 2022 | 35354255 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma. | Nat Commun | 2022 | 35347134 | PubTator, text mining | PubMed |
| The Interplay between Tumour Microenvironment Components in Malignant Melanoma. | Medicina (Kaunas) | 2022 | 35334544 | PubTator, text mining | PubMed |
| The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients. | Cancers (Basel) | 2022 | 35326719 | PubTator, text mining | PubMed |
| Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells. | Antioxidants (Basel) | 2022 | 35326180 | PubTator, text mining | PubMed |
| Facile discovery of surrogate cytokine agonists. | Cell | 2022 | 35325595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=35